89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study
Conditions: Breast Cancer; Metastatic Breast Cancer; HER2-positive Breast Cancer; Gastric Cancer; Metastatic Gastric Cancer; HER2-positive Gastric Cancer Intervention: Diagnostic Test: 89Zr-DFO*-trastuzumab PET scan Sponsors: Amsterdam UMC, location VUmc; AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: AstraZeneca | Breast Cancer | Cancer | Cancer & Oncology | Gastric (Stomach) Cancer | Gastroenterology | HER2 | Herceptin | PET Scan | Research | Study